Evidence map›Paper›PMID 40734459›Full record

ArticleScience progress

Prognostic impact of peripheral blood ratio in sinonasal squamous cell carcinoma.

Tian Wang, Qi Zhang, Li Wang, Jie Wang, Keqing Zhao, Xinmao Song

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tian WangDepartment of Radiation Oncology, Eye & ENT Hospital, Fudan University, Shanghai, China.ORCID 0000-0003-1861-6252
Qi ZhangDepartment of Ophthalmology, Shanghai Public Health Clinical Center, Shanghai, China.
Li WangDepartment of Radiation Oncology, Eye & ENT Hospital, Fudan University, Shanghai, China.ORCID 0000-0002-6358-597X
Jie WangDepartment of Radiation Oncology, Eye & ENT Hospital, Fudan University, Shanghai, China.
Keqing ZhaoDepartment of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.
Xinmao SongDepartment of Radiation Oncology, Eye & ENT Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ObjectiveSinonasal squamous cell carcinoma usually presents at an advanced stage at the time of diagnosis, and there is still a lack of indicators to predict the prognosis of sinonasal squamous cell carcinoma patients. We aim to investigate whether the peripheral blood ratios may be good options for predicting the progression in patients with sinonasal squamous cell carcinoma.MethodsWe performed a retrospective analysis of 198 patients with sinonasal squamous cell carcinoma between January 2010 and December 2022. The systemic inflammatory response index, platelet/lymphocyte ratio, neutrophil/lymphocyte ratio, and lymphocyte/monocyte ratio were calculated. We examined the predictive value for the prognosis of sinonasal squamous cell carcinoma patients.ResultsThe systemic inflammatory response index (1.21 vs. 0.79,

Indexed as

Carcinoma, Squamous CellAdultAgedAged, 80 and overBlood PlateletsFemaleHumansLymphocytesMaleMiddle AgedMonocytesNeoplasm StagingNeutrophilsPrognosisRetrospective Studiesmonocyte/lymphocyte rationeutrophil/lymphocyte ratioplatelet/lymphocyte ratioSinonasal squamous cell carcinomasystemic inflammatory response index

Identifiers

PMID40734459
PMCPMC12317209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.